Stelzer Laurie has filed 8 insider transactions across 4 companies since June 2023.
Most recent transaction: a grant/award of 32000 shares of MBX Biosciences, Inc. ($MBX) on January 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | MBX Biosciences, Inc. | $MBX | Stelzer Laurie | Not found | A | Stock option (right to buy) | 32000 | $0.00 | 32,000.0000 | 44,902,302 | 9999.99% | 0.07% |
| June 12, 2025 | Sionna Therapeutics, Inc. | $SION | Stelzer Laurie | Director | A | Non-Qualified Stock Option (right to buy) | 19959 | $0.00 | 19,959.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2025 | PMV Pharmaceuticals, Inc. | $PMVP | Stelzer Laurie | Not found | A | Stock Option (right to buy) | 33500 | $0.00 | 33,500.0000 | 51,933,604 | 9999.99% | 0.06% |
| May 29, 2025 | Spyre Therapeutics, Inc. | $SYRE | Stelzer Laurie | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 60,275,561 | 9999.99% | 0.04% |
| June 6, 2024 | PMV Pharmaceuticals, Inc. | $PMVP | Stelzer Laurie | Not found | A | Stock Option (right to buy) | 67500 | $0.00 | 67,500.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Spyre Therapeutics, Inc. | $SYRE | Stelzer Laurie | Not found | A | Stock Option (Right to Buy) | 11323 | $0.00 | 11,323.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2023 | Spyre Therapeutics, Inc. | $SYRE | Stelzer Laurie | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | PMV Pharmaceuticals, Inc. | $PMVP | Stelzer Laurie | Director | A | Stock Option (right to buy) | 21500 | $0.00 | 21,500.0000 | 0 | 9999.99% | 0.00% |